General Information of the Compound
Compound ID
CP0050731
Compound Name
4-N-(3-bromophenyl)pyrido[2,3-d]pyrimidine-4,7-diamine
    Show/Hide
Structure
Formula
C13H10BrN5
Molecular Weight
316.162
Canonical SMILES
Nc1ccc2c(Nc3cccc(Br)c3)ncnc2n1
    Show/Hide
InChI
InChI=1S/C13H10BrN5/c14-8-2-1-3-9(6-8)18-12-10-4-5-11(15)19-13(10)17-7-16-12/h1-7H,(H3,15,16,17,18,19)
    Show/Hide
InChIKey
FHXNETSSNWTSDM-UHFFFAOYSA-N
Physicochemical Property
logP
3.1131
Rotatable Bonds
2
Heavy Atom Count
19
Polar Areas
76.72
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5328267
SID: 15895302
ChEMBL ID
CHEMBL54474
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 = 940 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 954.99 nM